Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Post
-
-
Quotient and Ipsen extend partnership for ultra-rare disease therapy
Quotient Sciences has extended its commercial partnership with Ipsen, focusing on the production of Sohonos (Palovarotene) for fibrodysplasia ossificans progressiva …
-
ENDRA reports favourable data from Taeus Liver device study in MASLD
ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency in metabolic …
-
Lilly reports ACHIEVE-3 trial outcomes for type 2 diabetes
Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of …
-
Quantum acquires NeuWave Medical to enhance tumour ablation treatments
Quantum Surgical has acquired NeuWave Medical, supporting its strategy to broaden access to robotic-assisted tumour ablation treatments for reducing cancer …
-
Mahzi doses first patient in MZ-1866 trial for Pitt Hopkins syndrome
Mahzi Therapeutics has dosed the first patient in its Phase I/II UNITE study assessing MZ-1866, an investigational gene therapy targeting …
-
Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
-
Lilly reports ACHIEVE-3 trial outcomes for type 2 diabetes
Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of …
-
Quantum acquires NeuWave Medical to enhance tumour ablation treatments
Quantum Surgical has acquired NeuWave Medical, supporting its strategy to broaden access to robotic-assisted tumour ablation treatments for reducing cancer …
-
Mahzi doses first patient in MZ-1866 trial for Pitt Hopkins syndrome
Mahzi Therapeutics has dosed the first patient in its Phase I/II UNITE study assessing MZ-1866, an investigational gene therapy targeting …
-
Novo Nordisk and Vivtex collaborate for oral medicines development
Novo Nordisk and Vivtex have entered a partnership focused on developing next-generation oral biologic therapies to treat obesity, diabetes and …
-
Stryker unveils Synchfix EVT for flexible syndesmotic ankle fixation
US-based Stryker has launched Synchfix EVT, a flexible syndesmotic fixation device intended to simplify surgical procedures and support ankle stabilisation …
-
Vico Therapeutics initiates patient dosing for VO659 Phase I/IIa trial
Vico Therapeutics has started patient dosing in an expanded cohort under a twice-yearly regimen for its Phase I/IIa clinical trial …
-
NorthX Biologics and Demeetra collaborate on GMP manufacturing and CLD
NorthX Biologics and Demeetra have entered a strategic partnership focused on integrated cell line development (CLD) and good manufacturing practice …
-
Gossamer Bio reports topline Phase III PROSERA outcomes for PAH
Gossamer Bio has reported topline data from the Phase III PROSERA study evaluating seralutinib in patients with pulmonary arterial hypertension …
-
FDA approves Allurion’s PMA application for Gastric Balloon System
Allurion has received the US Food and Drug Administration (FDA) clearance for premarket approval (PMA) application for its Gastric Balloon …
-
AbbVie announces $380m investment in North Chicago API facilities
AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing facilities at its current …
